Strongyloidiasis: Understanding Parasitic Infections and Management
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: What is strongyloidiasis?
Strongyloidiasis is a parasitic infection caused by Strongyloides worms that enter through the skin from contaminated soil and migrate to the lungs and intestines, causing rashes, nausea and diarrhea. Because the worms can reinfect the host internally, it often becomes chronic. Treatment typically uses antiparasitic medications like ivermectin to eliminate the infection and prevent severe complications.
What the research says
Ivermectin cures more people than albendazole. A Cochrane review of seven trials (1,147 participants) found that, in four trials comparing the two drugs (478 participants), parasitological cure was higher with ivermectin (risk ratio 1.79, 95% CI 1.55–2.08), with no significant difference in side effects (Henriquez-Camacho et al., Cochrane Database Syst Rev, 2016) [2].
Weakened immunity makes the infection dangerous. A systematic review of 16 published cases of Strongyloides hyperinfection with blood clots found that 68.8% of patients were immunosuppressed, mostly because of corticosteroid therapy, and overall mortality reached 31.3%. The evidence comes from case reports only (López-Delgado et al., New Microbes New Infect, 2025) [3].
The choice of stool test matters. A meta-analysis of 40 studies found that formalin-ether concentration detected Strongyloides stercoralis more often than the single-slide Kato-Katz method (odds ratio 5.02, 95% CI 1.75–14.41) (Jongthawin et al., Parasit Vectors, 2026) [4].
What is strongyloidiasis, and how does it occur?
Strongyloidiasis is a chronic infection caused by the parasitic worm Strongyloides. These worms are found globally but are most prevalent in tropical and subtropical climates, as well as in rural or economically disadvantaged areas. In the United States, the infection is occasionally found in the South and Southeast, particularly in the Appalachian region. [1] Current estimates suggest that about 300 to 600 million people worldwide are infected, though many remain undiagnosed due to a lack of noticeable symptoms.
The infection process begins when young worms in contaminated soil penetrate the skin. Once they enter the body, they travel through the bloodstream to the lungs and eventually the gastrointestinal tract, where they mature and reproduce. [1] This unique life cycle allows the parasite to thrive and, in many cases, remain in the host's body for years if left untreated. [1]
What are the symptoms and common triggers of strongyloidiasis?
The symptoms of strongyloidiasis can be intermittent or entirely absent, making it a difficult condition to identify without medical testing. When symptoms do occur, they typically manifest in the skin, digestive system, or respiratory tract. The most distinctive sign is a raised, red, itchy rash known as larva currens, which often appears on the thighs, wrists, or between the buttocks. [1]
Digestive symptoms are also common as the worms mature in the intestines. Individuals may experience nausea, diarrhea, bloating, and upper abdominal pain that can feel similar to heartburn or a stomach ulcer. [1] Less frequently, a cough or scratchy throat may develop during the worms' migration through the lungs. [1]
Symptom Category | Common Manifestations |
|---|---|
Skin Symptoms | Raised, red, itchy rash (larva currens); irritation at the entry site. |
Digestive Issues | Nausea, diarrhea, upper abdominal pain, bloating. |
Respiratory Signs | Cough, scratchy throat (during lung migration). |
Systemic Risk | Risk of sepsis or pneumonia in individuals with weakened immune systems. [1] |
How does strongyloidiasis develop, and what is autoinfection?
One of the most concerning aspects of Strongyloides is its ability to perform autoinfection. This means the parasite can complete its entire life cycle—from laying eggs to hatching infectious larvae—completely inside the human body. This internal cycle allows the worms to reinfect the host repeatedly without any new contact with contaminated soil, leading to chronic infections that can last for decades.
For most people with a healthy immune system, the body can keep the infection in check, preventing it from causing severe illness. However, if the immune system becomes weakened—due to corticosteroid therapy, certain viral infections, or diseases affecting the bone marrow—the worms can invade other organs. This severe state, known as hyperinfection or disseminated strongyloidiasis, is life-threatening and can lead to systemic inflammation and bacterial infections in the bloodstream. [1]
How is strongyloidiasis diagnosed and tested?
Diagnosing strongyloidiasis requires specialized medical testing to identify the presence of the worms or their genetic markers in body fluids. Healthcare providers typically begin with a physical examination to look for characteristic rashes and discuss the patient's travel or work history, particularly contact with soil.
Stool Testing: Samples are analyzed to look for larvae or eggs. [1]
Blood Tests: Used to detect antibodies produced by the immune system in response to the infection.
Sputum Analysis: In some cases, mucus coughed up from the lungs is tested if respiratory symptoms are prominent.
Test Type | Purpose |
|---|---|
Stool Sample | Direct identification of larvae or eggs in the digestive tract. |
Antibody Test | Detection of the immune system's response to the parasite. |
Sputum Test | Checking for larvae in the lungs or respiratory secretions. |
How is strongyloidiasis managed and prevented?
The primary goal of treatment is to eliminate the parasite from the body and prevent the risk of hyperinfection. The most effective treatment is a course of antiparasitic medication. Ivermectin is considered the first-line therapy and is sometimes used in combination with albendazole. [1] [2] The duration of treatment varies, typically ranging from two to 14 days, depending on the severity of the infection and the patient's immune status. [1]
Prevention focuses on reducing contact with contaminated soil. In areas where the parasite is known to live, individuals should wear protective clothing, including shoes and gloves, when working or walking outdoors. [1] Additionally, individuals scheduled for procedures that will weaken their immune system should be screened for the infection beforehand to ensure it is treated while their immune system is still strong. [1]
Conclusion
Strongyloidiasis is a complex parasitic infection that requires careful management, particularly for those at risk of immune suppression. While the infection can remain hidden for years, modern antiparasitic treatments are highly effective at curing the condition in healthy individuals. Early diagnosis and proactive screening are essential tools in preventing the life-threatening complications associated with hyperinfection.
What are the next steps for strongyloidiasis?
If you have symptoms of a parasitic infection or have recently traveled to an area where Strongyloides is common, consult a healthcare professional for screening. Early intervention is the most effective way to ensure a full recovery and prevent long-term health complications.
Trusted resources: World Health Organization: Soil-transmitted helminth infections
Related reading on Rinnit: Parasites: Types, Symptoms, and Prevention Strategies · Roundworms: Symptoms, Causes, and Prevention Guide · Immunosuppressants: A Guide to Managing Your Immune System · Pinworm Infection: Complete Guide to Symptoms, Causes, and Treatment
Frequently Asked Questions
What is strongyloidiasis?
Strongyloidiasis is an infection caused by the Strongyloides parasitic worm, which typically enters the body through the skin.
How do people get infected?
Infection occurs through contact with soil contaminated with the larvae of the worm.
What is autoinfection?
Autoinfection is a process where the worm completes its life cycle entirely inside the host's body, leading to a continuous, chronic infection.
Who is at the highest risk for severe illness?
Individuals with weakened immune systems, such as those on corticosteroid therapy or with HTLV-1, are at high risk.
What is hyperinfection?
Hyperinfection is a life-threatening state where the worms spread rapidly throughout the body, often occurring in immune-compromised individuals.
What are the common skin symptoms?
The most common sign is an itchy, red, raised rash called larva currens.
Can strongyloidiasis cause digestive problems?
Yes, it can cause nausea, diarrhea, bloating, and upper abdominal pain.
Is the infection contagious?
Strongyloidiasis is generally not contagious between people, though rare cases of transmission through organ transplants have occurred.
How is the condition diagnosed?
Doctors use stool, blood, and sometimes sputum tests to look for signs of the parasite.
What is the most effective treatment?
Antiparasitic medications, specifically ivermectin, are the most effective treatments.
How long does treatment take?
Treatment typically lasts between two and 14 days, though it may be longer for severe cases.
Can strongyloidiasis be cured?
Yes, it can be cured with appropriate antiparasitic medication, especially in individuals with healthy immune systems.
Where is the parasite most commonly found?
The Strongyloides parasite is found worldwide but is most common in tropical and subtropical regions.
How can I prevent infection?
Wear shoes and gloves when in contact with soil in high-risk areas and ensure proper sanitation.
When should I see a doctor?
See a provider if you have symptoms, a weakened immune system, or are starting treatments that will suppress your immune system.
References
Cleveland Clinic. Strongyloidiasis. Cleveland Clinic. Last updated August 13, 2026. https://my.clevelandclinic.org/health/diseases/14074-strongyloidiasis
Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016;2016(1):CD007745. PMID 26778150. https://doi.org/10.1002/14651858.CD007745.pub3
López-Delgado DS, Narváez CA, Bonfante-Villalobos R, et al. Strongyloides hyperinfection with thrombosis: a systematic review of case reports. New Microbes New Infect. 2025;68:101659. PMID 41323851. https://doi.org/10.1016/j.nmni.2025.101659
Jongthawin J, Mahittikorn A, Wangdi K, et al. Comparison of Ritchie and Kato-Katz methods for the detection of intestinal helminths in humans: a systematic review and meta-analysis. Parasit Vectors. 2026;19(1). PMID 42141455. https://doi.org/10.1186/s13071-026-07437-7
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Comments